VALERITAS HOLDINGS COM (VLRX)

6.50
OTC Markets
Prev Close 6.50
Day Low/High 0.00 / 0.00
52 Wk Low/High 6.00 / 6.50
Exchange OTC Markets
Shares Outstanding 47.09B
Market Cap 306.06M
Div & Yield N.A. (N.A)

Valeritas Announces Retrospective Analysis Of The V-Go® Disposable Insulin Delivery Device Published Online In Drugs-Real World Outcomes, An International, Peer-Reviewed Journal

Data show that switching to V-Go for insulin delivery in a poorly controlled diabetes population at high risk results in significant glycemic improvement and payer cost savings

Valeritas Presents Positive Results Of Five Real-World Studies Of The V-Go® Disposable Insulin Delivery Device At AACE 2016

Results support previous findings that V-Go helps patients with diabetes improve glucose control while using less insulin

Valeritas Completes Alternative Public Offering And Raises Gross Proceeds Of $25.2 Million

Funding Will Support Continued Commercialization of the V-Go® Disposable Insulin Delivery Device and Advance Next Generation Products

Indevus Buying Valera

It sees a strong urology focus.